Q2 2025 |
42 |
$977M |
+$143M |
-$67.7M |
+$75.4M |
SLNO, VRNA, CDTX, GERN, SVA
|
13F-HR |
8/13/2025, 07:30 PM |
Q1 2025 |
40 |
$755M |
+$24.5M |
-$207M |
-$182M |
SLNO, VRNA, GERN, TRVI, AVDL
|
13F-HR |
5/12/2025, 08:00 AM |
Q4 2024 |
40 |
$893M |
+$73.8M |
-$273M |
-$199M |
SLNO, VRNA, GERN, TERN, AVDL
|
13F-HR |
2/13/2025, 01:12 PM |
Q3 2024 |
43 |
$1.21B |
+$76.9M |
-$184M |
-$107M |
SLNO, GERN, HRMY, VRNA, SVA
|
13F-HR |
11/13/2024, 05:13 PM |
Q2 2024 |
42 |
$1.08B |
+$42.4M |
-$114M |
-$71.4M |
SLNO, GERN, HRMY, SVA, DYN
|
13F-HR |
8/14/2024, 06:30 AM |
Q1 2024 |
39 |
$1.23B |
+$164M |
-$239M |
-$74.6M |
SLNO, GERN, HRMY, SVA, AVDL
|
13F-HR |
4/22/2024, 05:08 PM |
Q4 2023 |
47 |
$1.22B |
+$290M |
-$154M |
+$136M |
SLNO, GRCL, VRNA, HRMY, ALXO
|
13F-HR |
2/6/2024, 06:39 PM |
Q3 2023 |
54 |
$802M |
+$198M |
-$82.4M |
+$115M |
SLNO, HRMY, VRNA, AVDL, TARS
|
13F-HR |
11/8/2023, 04:00 PM |
Q2 2023 |
51 |
$827M |
+$69.7M |
-$70.7M |
-$956K |
HRMY, VRNA, AVDL, TERN, GERN
|
13F-HR |
8/14/2023, 05:04 PM |
Q1 2023 |
46 |
$1.33B |
+$23.3M |
-$25.1M |
-$1.78M |
SVA, VRNA, HRMY, TERN, VRDN
|
13F-HR |
5/12/2023, 09:46 PM |
Q4 2022 |
45 |
$783M |
+$75M |
-$56.6M |
+$18.4M |
HRMY, TERN, VRDN, ALXO, GERN
|
13F-HR |
2/13/2023, 04:08 PM |
Q3 2022 |
50 |
$904M |
+$102M |
-$159M |
-$56.5M |
HRMY, TIL, VTYX, VRNA, ALXO
|
13F-HR |
11/14/2022, 02:22 PM |
Q2 2022 |
48 |
$994M |
+$4.33M |
-$78.2M |
-$73.9M |
HRMY, SRRA, TIL, ISEE, SVA
|
13F-HR |
8/12/2022, 05:59 PM |
Q1 2022 |
54 |
$1.45B |
+$99.2M |
-$36.9M |
+$62.3M |
HRMY, NFH, TIL, ISEE, SRRA
|
13F-HR |
5/13/2022, 04:00 PM |
Q4 2021 |
55 |
$1.66B |
+$120M |
-$67.9M |
+$52.4M |
TIL, HRMY, NFH, ISEE, ALXO
|
13F-HR |
2/11/2022, 03:01 PM |
Q3 2021 |
60 |
$2.23B |
+$129M |
-$294M |
-$165M |
ALXO, TIL, HRMY, NFH, AMRSQ
|
13F-HR |
11/15/2021, 12:24 PM |
Q2 2021 |
59 |
$2.31B |
+$48.4M |
-$257M |
-$209M |
TIL, ALXO, ASND, AMRSQ, NFH
|
13F-HR |
8/16/2021, 04:03 PM |
Q1 2021 |
63 |
$2.85B |
+$598M |
-$107M |
+$491M |
TIL, ALXO, AMRSQ, ASND, NFH
|
13F-HR |
5/17/2021, 03:46 PM |
Q4 2020 |
58 |
$2.2B |
+$354M |
-$241M |
+$112M |
ALXO, ASND, HRMY, TARS, NFH
|
13F-HR |
2/16/2021, 01:39 PM |
Q3 2020 |
64 |
$1.73B |
+$483M |
-$28.6M |
+$455M |
ASND, ALXO, HRMY, NFH, LEGN
|
13F-HR |
11/13/2020, 03:34 PM |
Q2 2020 |
54 |
$1.39B |
+$385M |
-$245M |
+$140M |
ASND, LEGN, NFH, GTH, PASG
|
Restatement |
11/13/2020, 03:35 PM |
Q1 2020 |
53 |
$1.1B |
+$1.1B |
|
+$1.1B |
ASND, NFH, KDMN, ARQT, CRNX
|
13F-HR |
5/15/2020, 04:06 PM |
Q4 2019 |
4 |
$1.37M |
+$184K |
|
+$184K |
|
Restatement |
2/24/2020, 04:33 PM |
Q3 2019 |
5 |
$879M |
+$879M |
|
+$879M |
|
13F-HR |
11/13/2019, 03:56 PM |
Q2 2019 |
45 |
$1.03B |
+$155M |
-$3.32M |
+$152M |
ASND, CRNX, ARWR, TCDAQ, CDXS
|
13F-HR |
8/13/2019, 04:33 PM |
Q1 2019 |
49 |
$1B |
+$103M |
-$115M |
-$12.5M |
ASND, CRNX, CDXS, ARWR, KALV
|
13F-HR |
5/13/2019, 05:52 PM |
Q4 2018 |
45 |
$783M |
+$40.4M |
-$26.6M |
+$13.8M |
ASND, CRNX, BHVNXXXX, CDXS, SVA
|
13F-HR |
2/13/2019, 03:01 PM |
Q3 2018 |
43 |
$991M |
+$258M |
-$25.5M |
+$233M |
ASND, CRNX, BHVNXXXX, CDXS, SVA
|
13F-HR |
11/13/2018, 01:54 PM |
Q2 2018 |
38 |
$704M |
+$119M |
-$11.6M |
+$107M |
ASND, BHVNXXXX, CDXS, ACRS, MNLO
|
13F-HR |
8/10/2018, 04:31 PM |
Q1 2018 |
34 |
$706M |
+$237M |
-$18.8M |
+$218M |
MNLO, ASND, BHVNXXXX, CDXS, APLS
|
13F-HR |
5/15/2018, 01:07 PM |
Q4 2017 |
30 |
$467M |
+$43.2M |
-$40M |
+$3.2M |
ASND, BHVNXXXX, ACRS, APLS, CDXS
|
13F-HR |
2/9/2018, 12:45 PM |
Q3 2017 |
29 |
$495M |
+$190M |
-$23.7M |
+$166M |
BHVNXXXX, ACRS, ASND, KALA, VRNA
|
13F-HR |
11/13/2017, 02:29 PM |
Q2 2017 |
26 |
$397M |
+$88.3M |
-$4.88M |
+$83.5M |
ACRS, ASND, NBRVXXXX, CDXS, SELB
|
13F-HR |
8/2/2017, 05:19 PM |
Q1 2017 |
23 |
$340M |
+$14.4M |
-$19.2M |
-$4.82M |
ACRS, ASND, NBRVXXXX, CDXS, EIGR
|
13F-HR |
5/15/2017, 11:30 AM |
Q4 2016 |
25 |
$303M |
+$24.1M |
-$36.6M |
-$12.4M |
ACRS, ASND, CDXS, NBRVXXXX, EIGR
|
Restatement |
4/6/2017, 06:08 AM |
Q3 2016 |
22 |
$321M |
+$19M |
-$1.24M |
+$17.8M |
ACRS, ASND, EIGR, CDXS, NBRVXXXX
|
13F-HR |
11/14/2016, 07:10 AM |
Q2 2016 |
23 |
$366M |
+$18.3M |
-$2.34M |
+$15.9M |
SGNT, ACRS, EIGR, NBRVXXXX, ASND
|
13F-HR |
8/15/2016, 09:19 AM |
Q1 2016 |
21 |
$357M |
|
|
|
ACRS, SGNT, NBRVXXXX, EIGR, ASND
|
13F-HR |
5/16/2016, 01:39 PM |